Migraine diagnosis in patients with sinus headache symptoms: a cross-sectional study at Khartoum ENT Hospital
Abstract
Sinus headache is the most common diagnosis reported by patients with migraine who received a non-migraine diagnosis. Thus, the aim of this study was to determine the prevalence of migraine among patients present with sinus headache to Khartoum ENT Hospital. To study the prevalence of migraine (using IHS criteria) among patients present with sinus headache at Khartoum ENT Hospital. This is a cross-sectional hospital-based study conducted at Khartoum ENT Hospital in the period between July 2022 to February 2023 including all patients with self-reported or physician diagnosed “sinus headache”, without a suspected secondary cause of headache. Diagnosis of migraine was made using the IHS criteria. Data was collected by the researcher, entered and analyzed using SPSS. This study included 197 patients with a mean age of 33 ± 10 years, and female predominance 129 (65. 5%). The most common presentation was nasal blockage 178 (90.4%), flowed by facial pain 87 (44.7%), and nasal discharge 42 (21.3%). Autonomic symptoms included lacrimation 71 (36%), conjunctival injection 20 (10%), and eyelid edema 6 (3%), and 26 (13%) had positive family history of migraine. The prevalence of migraine was 67 (34%); 40 (20%) without aura and 27 (14%) with aura. Migraine was significantly associated with autonomic symptoms, and family history of migraine, and poor response to NSAIDs and nasal sprays compared to non-migraine headache (P-value < 0.05). Migraine is not uncommon as 34% of patients with…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 197 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.